Alexander Hardy
Director Ejecutivo en BIOMARIN PHARMACEUTICAL INC. .
Fortuna: 10 M $ al 31/05/2025
Perfil
Alexander Hardy currently works at BioMarin Pharmaceutical, Inc., as President, Chief Executive Officer & Director from 2023, Pharmaceutical Research & Manufacturers of America, as Director, and The Wall Street Journal CEO Council, as Member.
Mr. Hardy also formerly worked at Genentech, Inc., as Chief Executive Officer & Director.
Mr. Hardy received his undergraduate degree from the University of Cambridge and Masters Business Admin degree from Stephen M.
Ross School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
17/03/2025 | 175.583 ( 0,09 % ) | 10 M $ | 31/05/2025 |
Últimas noticias acerca de Alexander Hardy
Cargos activos de Alexander Hardy
Empresas | Cargo | Inicio |
---|---|---|
BIOMARIN PHARMACEUTICAL INC. | Director Ejecutivo | 01/12/2023 |
The Wall Street Journal CEO Council | Corporate Officer/Principal | - |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Alexander Hardy.
Empresas | Cargo | Fin |
---|---|---|
Genentech, Inc.
![]() Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Ejecutivo | - |
Formación de Alexander Hardy.
University of Cambridge | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. Pharmaceuticals: MajorHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Wall Street Journal CEO Council | |
Pharmaceutical Research & Manufacturers of America
![]() Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
- Bolsa de valores
- Insiders
- Alexander Hardy